Informationen:
Fehler:
ID
19072
Beschreibung
PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone; ODM derived from: https://clinicaltrials.gov/show/NCT00291005
Link
https://clinicaltrials.gov/show/NCT00291005
Stichworte
Versionen (1)
- 03.12.16 03.12.16 -
Hochgeladen am
3. Dezember 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Prostatic Neoplasms NCT00291005
Eligibility Prostatic Neoplasms NCT00291005
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Prostatic Neoplasms NCT00291005
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender | Adenocarcinoma of prostate | Metastatic Lesion Quantity | Measurable Disease | Hormone Therapy | Disease Progression
Item
men with prostate adenocarcinoma with at least one metastatic lesion which is measurable and who progressed after prior hormonal therapy.
boolean
C0079399 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
C1513183 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1513041 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0242656 (UMLS CUI [6])
C0007112 (UMLS CUI [2])
C1513183 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1513041 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0242656 (UMLS CUI [6])
Body temperature measurement Degrees Celsius
Item
1.body temperature > 38 degree centigrade.
boolean
C0886414 (UMLS CUI [1,1])
C0439237 (UMLS CUI [1,2])
C0439237 (UMLS CUI [1,2])
Therapeutic radiology procedure Bone Marrow Percentage
Item
2.prior radiotherapy to > 25% of bone marrow.
boolean
C1522449 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Radionuclide therapy | Brachytherapy
Item
3.prior isotope therapy and/or brachytherapy
boolean
C0203608 (UMLS CUI [1])
C0006098 (UMLS CUI [2])
C0006098 (UMLS CUI [2])
gene therapy
Item
4.prior gene therapy.
boolean
C0017296 (UMLS CUI [1])
Malignant Neoplasm double
Item
5.active double cancer.
boolean
C0006826 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C0205173 (UMLS CUI [1,2])
Brain Involvement | Leptomeninges Involvement
Item
6.known brain or leptomeningeal involvement.
boolean
C0006104 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0228126 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [1,2])
C0228126 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Drug Allergy
Item
7.history of hypersensitivity reaction to drug
boolean
C0013182 (UMLS CUI [1])
Illness Serious | Medical condition Serious
Item
8.other serious illness or medical condition
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Social Conditions Study Subject Participation Status Exclusion | Medical condition Study Subject Participation Status Exclusion
Item
9.subjects whom the investigators consider inappropriate from social or medical aspects.
boolean
C0037403 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])